Decreased NOS3 expression could lead to lower nitric oxide (NO) bioavailability, a hallmark of endothelial dysfunction [40], while increased PAI-1 could stimulate atherosclerosis and clot stability (Figure 8). The gene discussed is NOS3; the disease is endothelial dysfunction.